Lucerna will be presenting at the 3rd RNA-Targeted Drug Discovery Summit: December 8-10, 2020 Virtual Talk Presentation: “Spinach splice sensor: a cell-based drug discovery platform for…
Year: 2020
On Thursday, May 28th, 2020, Lucerna will be giving a virtual talk to present the latest advances in its high-throughput RNA splicing drug discovery platform at the…
Lucerna is announcing the launch of a new R&D program to develop a new high-throughput screening (HTS) platform to enable the rapid discovery of drugs that…
Today, Lucerna announced the launch of the newest member in its fluorophore product line, DFHBI-BI or BI. A derivative of DFHBI, BI is the first photostable green…
Lucerna has received a 1 year $225K SBIR Phase I grant from the National Institute of Allergy and Infectious Diseases to develop new high-throughput screening (HTS)…
Lucerna has received a 2 year $1.5M SBIR Phase II contract from the National Cancer Institute to develop new R&D tools to enable scientists to better…
Lucerna will be presenting at SLAS 2020 International Conference & Exhibition: January 25-29, 2020 San Diego, CA Booth # 2029M Innovation AveNEW Ignite Award Presentation: Monday,…